Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis
项目 3-白细胞-血小板相互作用在炎症和血栓形成中的作用
基本信息
- 批准号:10268699
- 负责人:
- 金额:$ 53.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAdaptive Immune SystemAdhesivesAffectAfrican AmericanArterial InjuryArthritisAttenuatedAutoantibodiesAutoimmune DiseasesBindingBinding SitesBiochemicalBiological MarkersBloodBlood PlateletsBlood VesselsBrainCardiovascular DiseasesCaucasiansCell AdhesionCell Adhesion MoleculesCellsClinicalCognitiveComplexCross-Sectional StudiesCytoplasmic TailCytotoxic agentDepositionDevelopmentDiseaseDisease modelExanthemaFOXP1 geneFatigueFlareFunctional disorderGenerationsGlomerulonephritisHairHemostatic functionHispanicsIRAK1 geneITGAM geneITGB2 geneImmune System DiseasesImmunosuppressive AgentsImpairmentInflammasomeInflammationInflammatoryInnate Immune SystemIntegrinsInterruptionJointsKidneyLaboratoriesLasersLeukocytesLigand BindingLigationLungLupusMacrophage-1 AntigenMediatingMethodsMicrocirculationModelingMolecularMonoclonal AntibodiesMultiple SclerosisMusMutant Strains MiceNatureNuclearObservational StudyOrganPainPathogenesisPatient AgentsPatientsPeptidesPopulationPrevalencePreventionProcessReportingRoleSerumSignal TransductionSiteSkinStable DiseaseStrokeStructureSurvival RateSymptomsSystemic Lupus ErythematosusSystemic diseaseTalinTherapeutic immunosuppressionThrombosisTimeTissuesVasculitisVenousVenous ThrombosisWomanbasechronic painexperienceexperimental studyextracellularforkhead proteinhealth disparityin vivoinsightmacrophagemonocytemouse modelneutrophilnovelnovel therapeuticsreceptorrecruitresponserestenosistherapeutically effectivethromboticvascular injury
项目摘要
PROJECT SUMMARY/ABSTRACT
This translational project will focus on systemic lupus erythematosus (SLE) as a unique disease model
of inflammation and thrombosis. SLE is a complex autoimmune disease. The prevalence of SLE ranges
from 20 to 150 cases per 100,000 population. SLE affects primarily women and there is a significant impact
of health disparities in patients with Lupus. SLE is 2-3 times more prevalent among African American and
Hispanic than among Caucasian women. Patients with SLE can experience significant symptoms, such as
chronic pain, extreme fatigue, hair loss, cognitive issues, and physical impairments that affect every facet
of their lives. Many suffer from cardiovascular disease, strokes, disfiguring rashes, and painful arthritis.
The 10-year survival rate is about 70%. Historically, SLE has been considered as an adaptive immune
system disorder characterized by the presence in patient serum of autoantibodies raised against nuclear
components which deposit in blood vessels, skin, kidney, lung, joints and brain causing tissue damage
and clinical manifestations. New advances in the understanding of SLE pathogenesis have focused on the
innate immune system, with a particular focus on leukocytes (i.e., neutrophils, monocytes) as key players
in perpetuating and amplifying this systemic disease. Currently, there is no prevention or cure for SLE, and
the mainstay of treatment is non-specific immunosuppressive and cytotoxic agents. Thus, there is
significant unmet clinical need in SLE and compelling demand for more effective therapeutic approaches.
Leukocyte-platelet interactions induce bidirectional signals that amplify pro-inflammatory and pro-
thrombotic cellular responses. We have focused on the leukocyte integrin Mac-1 (αMβ2), identifying this
adhesive receptor as a critical molecular determinant of leukocyte recruitment and signaling. Our
laboratory first reported the interaction between Mac-1 and its platelet counter-receptor GPIbα and
determined the molecular basis of GPIb recognition. We established that Mac-1:GPIbα broadly regulates
inflammation in models of vasculitis, glomerulonephritis, and multiple sclerosis as well as arterial
thrombosis. The central hypothesis of this proposal is that the Mac-1:GPIbα interaction is broadly required
for inflammation and initiates pro-inflammatory and prothrombotic signals that promote diverse disease
processes. The specific aims of the project are: 1) To determine the effect of disrupting Mac-1:GPIbα on
the progression and complications of SLE using mouse models; 2) To define the physical determinants of
Mac-1:GPIbα binding and the nature of “outside-in” signals generated by this interaction; and 3) To provide
evidence that clinical SLE disease activity is correlated with biomarkers of the Mac-1:GPIbα interaction.
Because leukocyte-platelet interactions broadly regulate inflammation and thrombosis, understanding the
molecular machinery of this cellular complex will provide important insights for developing new therapies
directed at reducing end-organ damage in SLE and other inflammatory/thrombotic disorders.
项目总结/摘要
这个翻译项目将集中在系统性红斑狼疮(SLE)作为一种独特的疾病模型
炎症和血栓形成SLE是一种复杂的自身免疫性疾病。SLE的患病率范围
从每10万人20例增加到150例。SLE主要影响女性,
狼疮患者的健康差异。SLE在非裔美国人中的患病率是非裔美国人的2-3倍,
西班牙裔女性多于白人女性。SLE患者可能会出现明显的症状,例如
慢性疼痛、极度疲劳、脱发、认知问题和影响各个方面的身体损伤
他们的生活。许多人患有心血管疾病、中风、毁容皮疹和疼痛的关节炎。
10年生存率约为70%。从历史上看,SLE一直被认为是一种适应性免疫,
以患者血清中存在抗核抗体为特征的一种系统疾病
存款在血管,皮肤,肾脏,肺,关节和大脑造成组织损伤的成分
和临床表现。SLE发病机制的新进展主要集中在
先天免疫系统,特别关注白细胞(即,中性粒细胞,单核细胞)作为关键参与者
使这种系统性疾病延续和扩大。目前,没有预防或治愈SLE,
治疗的主要手段是非特异性免疫抑制剂和细胞毒性剂。因此,
SLE中显著未满足的临床需求和对更有效治疗方法的迫切需求。
白细胞-血小板相互作用诱导双向信号,其放大促炎性和促血小板活化作用。
血栓细胞反应。我们重点研究了白细胞整合素Mac-1(αMβ2),
粘附受体作为白细胞募集和信号传导的关键分子决定因素。我们
实验室首次报道了Mac-1与其血小板反受体GPIbα之间的相互作用,
确定了GPIb识别的分子基础。我们确定Mac-1:GPIbα广泛调节
血管炎、肾小球肾炎和多发性硬化模型中的炎症以及动脉炎
血栓形成该建议的中心假设是Mac-1:GPIbα相互作用是广泛需要的
并启动促炎和促血栓形成信号,促进各种疾病
流程.本项目的具体目标是:1)确定干扰Mac-1:GPIbα对
使用小鼠模型研究SLE的进展和并发症; 2)确定SLE的物理决定因素,
Mac-1:GPIbα结合和这种相互作用产生的“由外向内”信号的性质;以及3)提供
临床SLE疾病活动性与Mac-1:GPIbα相互作用的生物标志物相关的证据。
由于白细胞-血小板相互作用广泛地调节炎症和血栓形成,
这种细胞复合体的分子机制将为开发新疗法提供重要的见解
旨在减少SLE和其他炎性/血栓性疾病中的终末器官损伤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel I Simon其他文献
406-4 Mice lacking the transcription factor CHF1/Hey2 show decreased arterial neointimal formation after injury and impaired vascular smooth muscle cell responsiveness to growth factors
- DOI:
10.1016/s0735-1097(04)92263-2 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Yasuhiko Sakata;Fan Xiang;Zhiping Chen;Yoriko Kiriyama;Caramai N Kamei;Daniel I Simon;Michael T Chin - 通讯作者:
Michael T Chin
Daniel I Simon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel I Simon', 18)}}的其他基金
Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis
项目 3-白细胞-血小板相互作用在炎症和血栓形成中的作用
- 批准号:
10661640 - 财政年份:2021
- 资助金额:
$ 53.61万 - 项目类别:
Project 3- Role of Leukocyte-Platelet Interactions in Inflammation and Thrombosis
项目 3-白细胞-血小板相互作用在炎症和血栓形成中的作用
- 批准号:
10471914 - 财政年份:2021
- 资助金额:
$ 53.61万 - 项目类别:
Monocyte Differentiation and Mac-1-Regulated Forkhead
单核细胞分化和 Mac-1 调节的叉头
- 批准号:
6909940 - 财政年份:2003
- 资助金额:
$ 53.61万 - 项目类别:
Monocyte Differentiation and Mac-1-Regulated Forkhead
单核细胞分化和 Mac-1 调节的叉头
- 批准号:
6668851 - 财政年份:2003
- 资助金额:
$ 53.61万 - 项目类别:
相似海外基金
Single-cell analysis of adaptive immune system cells in IBD patients
IBD 患者适应性免疫系统细胞的单细胞分析
- 批准号:
22KJ2212 - 财政年份:2023
- 资助金额:
$ 53.61万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 53.61万 - 项目类别:
Elucidation of the adaptive immune system in teleost fish
阐明硬骨鱼的适应性免疫系统
- 批准号:
22K05824 - 财政年份:2022
- 资助金额:
$ 53.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
- 批准号:
10434937 - 财政年份:2021
- 资助金额:
$ 53.61万 - 项目类别:
Peripheral Adaptive Immune System Changes Associated with Alzhiemer's Disease
与阿尔茨海默病相关的外周适应性免疫系统变化
- 批准号:
10194864 - 财政年份:2021
- 资助金额:
$ 53.61万 - 项目类别:
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
- 批准号:
10302501 - 财政年份:2021
- 资助金额:
$ 53.61万 - 项目类别:
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
- 批准号:
10275426 - 财政年份:2021
- 资助金额:
$ 53.61万 - 项目类别:
CAREER: Emergence of Functional Organization in the Adaptive Immune System
职业:适应性免疫系统中功能组织的出现
- 批准号:
2045054 - 财政年份:2021
- 资助金额:
$ 53.61万 - 项目类别:
Continuing Grant
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
- 批准号:
10669709 - 财政年份:2021
- 资助金额:
$ 53.61万 - 项目类别:
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
- 批准号:
10467050 - 财政年份:2021
- 资助金额:
$ 53.61万 - 项目类别: